Oral Antibiotic Treatment for Strep Throat

First-Line Treatment for Non-Allergic Patients

The American Academy of Family Physicians and the Infectious Diseases Society of America recommend penicillin V or amoxicillin as the first-line oral antibiotics for strep throat, with penicillin V dosed at 250 mg twice or three times daily for children, or 250 mg four times daily (or 500 mg twice daily) for adolescents and adults, all for 10 days 1, 2
Penicillin V remains the drug of choice due to its proven efficacy, safety, narrow spectrum of activity, and low cost, as supported by the IDSA guidelines with strong, high-quality evidence 1, 2, 3
Amoxicillin is equally effective and often preferred in young children due to better palatability of the suspension, with dosing at 50 mg/kg once daily (maximum 1,000 mg) or 25 mg/kg twice daily (maximum 500 mg) for 10 days 1, 2, 4

For patients with non-immediate penicillin allergy, first-generation cephalosporins such as cephalexin (20 mg/kg/dose twice daily, maximum 500 mg/dose) or cefadroxil (30 mg/kg once daily, maximum 1 g) are appropriate for 10 days 1, 2
For patients with immediate penicillin allergy or severe reactions, alternatives include clindamycin (7 mg/kg/dose three times daily, maximum 300 mg/dose), azithromycin (12 mg/kg once daily, maximum 500 mg), or clarithromycin (7.5 mg/kg/dose twice daily, maximum 250 mg/dose), all with strong, moderate evidence 1, 2

A full 10-day course is required for most oral antibiotics to achieve maximal pharyngeal eradication of Group A streptococci, as recommended by the American Academy of Family Physicians and the Infectious Diseases Society of America 1, 2, 6
Azithromycin is the only exception, requiring only 5 days due to its prolonged tissue half-life 1, 2, 5

Benzathine penicillin G (intramuscular) is preferred when compliance with oral therapy is uncertain, with dosing at 600,000 units for patients under 27 kg and 1,200,000 units for patients 27 kg or greater as a single dose 1, 2, 4

Sulfonamides or tetracyclines should not be used for Group A streptococcal pharyngitis due to high resistance rates and frequent treatment failures, as advised by the Infectious Diseases Society of America 3, 5
Therapy can be safely delayed up to 9 days after symptom onset and still prevent rheumatic fever, allowing time for culture confirmation before initiating antibiotics 6